$2.51 Billion is the total value of Rock Springs Capital Management LP's 138 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 14.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | $128,436,000 | -10.9% | 591,000 | 0.0% | 5.12% | -1.9% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $111,061,000 | +28.6% | 1,232,500 | +20.5% | 4.42% | +41.6% |
| WCG | WELLCARE HEALTH PLANS INC | $83,064,000 | -9.1% | 320,500 | 0.0% | 3.31% | +0.2% | |
| ISRG | INTUITIVE SURGICAL INC | $82,339,000 | +2.9% | 152,500 | 0.0% | 3.28% | +13.4% | |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $70,494,000 | -19.7% | 4,650,000 | +2.8% | 2.81% | -11.5% |
| HCA | Buy | HCA HEALTHCARE INC | $56,296,000 | -8.5% | 467,500 | +2.7% | 2.24% | +0.8% |
| EHC | Buy | ENCOMPASS HEALTH CORP | $51,573,000 | +1.1% | 815,000 | +1.2% | 2.06% | +11.4% |
| ONCE | SPARK THERAPEUTICS INC | $49,011,000 | -5.3% | 505,371 | 0.0% | 1.95% | +4.3% | |
| TFX | TELEFLEX INC | $44,168,000 | +2.6% | 130,000 | 0.0% | 1.76% | +13.0% | |
| PCRX | Sell | PACIRA BIOSCIENCES | $43,781,000 | -19.5% | 1,150,000 | -8.0% | 1.74% | -11.3% |
| PODD | Buy | INSULET CORP | $42,964,000 | +47.2% | 260,500 | +6.5% | 1.71% | +62.1% |
| IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $41,131,000 | +4.1% | 555,000 | +11.1% | 1.64% | +14.7% |
| EW | EDWARDS LIFESCIENCES CORP | $40,353,000 | +19.0% | 183,500 | 0.0% | 1.61% | +31.2% | |
| ACHC | Buy | ACADIA HEALTHCARE COMPANY IN | $40,093,000 | +8.7% | 1,290,000 | +22.3% | 1.60% | +19.8% |
| MDCO | MEDICINES CO | $40,000,000 | +37.1% | 800,000 | 0.0% | 1.59% | +50.9% | |
| ABBV | Buy | ABBVIE INC | $39,753,000 | +264.4% | 525,000 | +250.0% | 1.58% | +301.0% |
| BSX | BOSTON SCIENTIFIC CORP | $39,469,000 | -5.3% | 970,000 | 0.0% | 1.57% | +4.3% | |
| EXAS | Buy | EXACT SCIENCES CORP | $39,017,000 | -16.7% | 431,750 | +8.8% | 1.56% | -8.3% |
| SYK | STRYKER CORP | $38,718,000 | +5.2% | 179,000 | 0.0% | 1.54% | +15.9% | |
| CHRS | COHERUS BIOSCIENCES INC | $38,089,000 | -8.3% | 1,880,000 | 0.0% | 1.52% | +1.0% | |
| VRTX | VERTEX PHARMACEUTICALS INC | $34,392,000 | -7.6% | 203,000 | 0.0% | 1.37% | +1.7% | |
| BAX | Buy | BAXTER INTL INC | $33,676,000 | +36.7% | 385,000 | +28.0% | 1.34% | +50.6% |
| RDUS | Buy | RADIUS HEALTH INC | $33,475,000 | +9.9% | 1,300,000 | +4.0% | 1.33% | +21.1% |
| CI | Buy | CIGNA CORP NEW | $32,923,000 | +14.6% | 216,900 | +19.0% | 1.31% | +26.3% |
| IDXX | IDEXX LABS INC | $32,686,000 | -1.2% | 120,200 | 0.0% | 1.30% | +8.8% | |
| PEN | Buy | PENUMBRA INC | $32,614,000 | -14.7% | 242,500 | +1.5% | 1.30% | -6.0% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $28,161,000 | +3.0% | 1,050,000 | +4.2% | 1.12% | +13.4% |
| GLPG | Buy | GALAPAGOS NVspon adr | $26,716,000 | +25.6% | 175,000 | +6.1% | 1.06% | +38.3% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $26,579,000 | +11.8% | 330,500 | +0.9% | 1.06% | +23.1% |
| BGNE | BEIGENE LTDsponsored adr | $26,304,000 | -1.2% | 214,800 | 0.0% | 1.05% | +8.8% | |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $26,010,000 | -29.4% | 608,000 | +4.8% | 1.04% | -22.2% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $25,421,000 | -48.5% | 337,500 | +3.8% | 1.01% | -43.3% |
| ALDR | Sell | ALDER BIOPHARMACEUTICALS INC | $24,518,000 | +33.3% | 1,300,000 | -16.8% | 0.98% | +46.9% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $24,502,000 | -15.5% | 333,500 | +8.5% | 0.98% | -7.0% |
| AMGN | New | AMGEN INC | $24,382,000 | – | 126,000 | +100.0% | 0.97% | – |
| TMO | THERMO FISHER SCIENTIFIC INC | $23,593,000 | -0.8% | 81,000 | 0.0% | 0.94% | +9.2% | |
| MOH | Buy | MOLINA HEALTHCARE INC | $23,535,000 | -20.2% | 214,500 | +4.1% | 0.94% | -12.1% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $23,486,000 | -12.8% | 272,400 | +6.0% | 0.94% | -3.9% |
| INCY | INCYTE CORP | $23,182,000 | -12.6% | 312,300 | 0.0% | 0.92% | -3.8% | |
| ALLK | Sell | ALLAKOS INC | $22,803,000 | +30.3% | 290,000 | -28.2% | 0.91% | +43.6% |
| NVTA | INVITAE CORP | $21,679,000 | -18.0% | 1,125,000 | 0.0% | 0.86% | -9.6% | |
| WST | Buy | WEST PHARMACEUTICAL SVSC INC | $21,628,000 | +25.7% | 152,500 | +10.9% | 0.86% | +38.4% |
| NVRO | Buy | NEVRO CORP | $20,848,000 | +64.5% | 242,500 | +24.0% | 0.83% | +81.0% |
| ARGX | ARGENX SEsponsored adr | $20,707,000 | -19.5% | 181,700 | 0.0% | 0.82% | -11.4% | |
| SGEN | SEATTLE GENETICS INC | $20,667,000 | +23.4% | 242,000 | 0.0% | 0.82% | +36.0% | |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $20,564,000 | -16.4% | 213,500 | 0.0% | 0.82% | -7.9% | |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $20,064,000 | -30.2% | 110,900 | +5.6% | 0.80% | -23.2% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $20,062,000 | -3.8% | 257,500 | +27.2% | 0.80% | +5.8% |
| RARX | Buy | RA PHARMACEUTICALS INC | $19,748,000 | -18.3% | 835,000 | +3.9% | 0.79% | -10.1% |
| EPZM | EPIZYME INC | $19,084,000 | -17.8% | 1,850,100 | 0.0% | 0.76% | -9.5% | |
| ZLAB | Buy | ZAI LAB LTDadr | $18,601,000 | -3.0% | 575,000 | +4.5% | 0.74% | +6.8% |
| CELG | CELGENE CORP | $18,385,000 | +7.4% | 185,150 | 0.0% | 0.73% | +18.4% | |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $18,114,000 | -12.7% | 1,577,893 | 0.0% | 0.72% | -3.9% | |
| FRPT | Buy | FRESHPET INC | $17,681,000 | +65.3% | 355,250 | +51.2% | 0.70% | +82.2% |
| ADPT | Sell | ADAPTIVE BIOTECHNOLOGIES COR | $16,841,000 | -41.9% | 545,000 | -9.2% | 0.67% | -36.0% |
| INSM | INSMED INC | $15,700,000 | -31.1% | 890,000 | 0.0% | 0.63% | -24.0% | |
| XENT | Buy | INTERSECT ENT INC | $14,841,000 | -17.5% | 872,500 | +10.4% | 0.59% | -9.1% |
| ARDX | Buy | ARDELYX INC | $14,360,000 | +166.9% | 3,055,261 | +52.8% | 0.57% | +193.3% |
| BHVN | BIOHAVEN PHARMACTL HLDG CO L | $14,331,000 | -4.7% | 343,500 | 0.0% | 0.57% | +5.0% | |
| ACHN | Buy | ACHILLION PHARMACEUTICALS IN | $13,770,000 | +74.2% | 3,825,000 | +29.7% | 0.55% | +92.0% |
| SAGE | SAGE THERAPEUTICS INC | $12,977,000 | -23.4% | 92,500 | 0.0% | 0.52% | -15.7% | |
| NVCR | Sell | NOVOCURE LTD | $12,900,000 | +4.6% | 172,500 | -11.5% | 0.51% | +15.2% |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $12,858,000 | -7.8% | 265,000 | 0.0% | 0.51% | +1.6% | |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $12,779,000 | +69.2% | 1,300,000 | +132.1% | 0.51% | +86.4% |
| GH | GUARDANT HEALTH INC | $12,128,000 | -26.1% | 190,000 | 0.0% | 0.48% | -18.5% | |
| IMMU | IMMUNOMEDICS INC | $11,868,000 | -4.4% | 895,000 | 0.0% | 0.47% | +5.3% | |
| BOLD | AUDENTES THERAPEUTICS INC | $11,517,000 | -25.8% | 410,000 | 0.0% | 0.46% | -18.3% | |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $11,421,000 | +34.3% | 352,500 | +106.7% | 0.46% | +47.7% |
| OBSV | Buy | OBSEVA SA | $11,329,000 | -10.6% | 1,360,000 | +21.4% | 0.45% | -1.5% |
| FGEN | FIBROGEN INC | $11,316,000 | -18.1% | 306,000 | 0.0% | 0.45% | -9.8% | |
| ODT | ODONATE THERAPEUTICS INC | $11,193,000 | -29.1% | 430,000 | 0.0% | 0.45% | -21.9% | |
| RTRX | RETROPHIN INC | $11,011,000 | -42.3% | 950,000 | 0.0% | 0.44% | -36.4% | |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $10,928,000 | -89.5% | 95,000 | -84.3% | 0.44% | -88.5% |
| TBPH | THERAVANCE BIOPHARMA INC | $10,714,000 | +19.3% | 550,000 | 0.0% | 0.43% | +31.4% | |
| ABT | New | ABBOTT LABS | $10,250,000 | – | 122,500 | +100.0% | 0.41% | – |
| TBIO | Buy | TRANSLATE BIO INC | $10,158,000 | -20.3% | 1,025,000 | +1.6% | 0.40% | -12.1% |
| ZGNX | Buy | ZOGENIX INC | $10,010,000 | -10.8% | 250,000 | +6.4% | 0.40% | -1.7% |
| CNC | New | CENTENE CORP DEL | $9,941,000 | – | 229,800 | +100.0% | 0.40% | – |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $9,605,000 | -21.3% | 142,500 | 0.0% | 0.38% | -13.3% | |
| PHR | New | PHREESIA INC | $8,751,000 | – | 361,000 | +100.0% | 0.35% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $8,485,000 | – | 250,000 | +100.0% | 0.34% | – |
| ANAB | Buy | ANAPTYSBIO INC | $8,398,000 | -31.9% | 240,000 | +9.8% | 0.34% | -24.9% |
| FOLD | AMICUS THERAPEUTICS INC | $8,020,000 | -35.7% | 1,000,000 | 0.0% | 0.32% | -29.2% | |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $7,948,000 | – | 790,048 | +100.0% | 0.32% | – |
| RIGL | RIGEL PHARMACEUTICALS INC | $7,854,000 | -28.4% | 4,200,000 | 0.0% | 0.31% | -21.2% | |
| FIXX | HOMOLOGY MEDICINES INC | $7,693,000 | -7.5% | 425,000 | 0.0% | 0.31% | +2.0% | |
| QURE | New | UNIQURE NV | $7,656,000 | – | 194,500 | +100.0% | 0.30% | – |
| JNJ | New | JOHNSON & JOHNSON | $7,245,000 | – | 56,000 | +100.0% | 0.29% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $6,730,000 | – | 187,000 | +100.0% | 0.27% | – |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $6,614,000 | +155.0% | 1,850,000 | +184.6% | 0.26% | +180.9% |
| RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $6,585,000 | +27.4% | 305,000 | +29.8% | 0.26% | +40.1% |
| ANTM | Buy | ANTHEM INC | $6,483,000 | +14.9% | 27,000 | +35.0% | 0.26% | +26.5% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $6,323,000 | -6.9% | 587,400 | +9.9% | 0.25% | +2.4% |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $6,152,000 | +12.3% | 800,000 | 0.0% | 0.24% | +23.7% | |
| MEDICINES COnote 2.750% 7/1 | $6,050,000 | +20.4% | 5,000,000 | 0.0% | 0.24% | +32.4% | ||
| PHAS | Sell | PHASEBIO PHARMACEUTICALS INC | $5,908,000 | -68.4% | 1,416,900 | -0.4% | 0.24% | -65.2% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $5,882,000 | -28.9% | 360,400 | -12.8% | 0.23% | -21.7% |
| SPRO | SPERO THERAPEUTICS INC | $5,565,000 | -7.9% | 525,000 | 0.0% | 0.22% | +1.4% | |
| RTIX | RTI SURGICAL HOLDINGS INC | $5,558,000 | -32.9% | 1,950,000 | 0.0% | 0.22% | -26.3% | |
| AXNX | Sell | AXONICS MODULATION TECH INC | $5,451,000 | -66.7% | 202,500 | -49.4% | 0.22% | -63.4% |
| MNTA | MOMENTA PHARMACEUTICALS INC | $5,184,000 | +4.1% | 400,000 | 0.0% | 0.21% | +15.0% | |
| AKRO | AKERO THERAPEUTICS INC | $5,119,000 | +18.8% | 225,000 | 0.0% | 0.20% | +30.8% | |
| INSMED INCnote 1.750% 1/1 | $5,031,000 | -14.0% | 6,000,000 | 0.0% | 0.20% | -5.7% | ||
| DERM | DERMIRA INC | $4,952,000 | -33.2% | 775,000 | 0.0% | 0.20% | -26.5% | |
| NGM | NGM BIOPHARMACEUTICALS INC | $4,863,000 | -5.4% | 351,100 | 0.0% | 0.19% | +4.3% | |
| CGEN | COMPUGEN LTDord | $4,653,000 | +10.2% | 1,100,000 | 0.0% | 0.18% | +20.9% | |
| CBAY | CYMABAY THERAPEUTICS INC | $4,608,000 | -28.5% | 900,000 | 0.0% | 0.18% | -21.0% | |
| Buy | NABRIVA THERAPEUTICS PLC | $4,600,000 | +18.3% | 2,300,000 | +43.8% | 0.18% | +29.8% | |
| MEDICINES COnote 2.500% 1/1 | $4,521,000 | +25.0% | 3,000,000 | 0.0% | 0.18% | +37.4% | ||
| CHMA | Buy | CHIASMA INC | $4,455,000 | -8.3% | 900,000 | +38.5% | 0.18% | +1.1% |
| CO | GLOBAL CORD BLOOD CORPORATIO | $4,477,000 | -16.3% | 925,000 | 0.0% | 0.18% | -7.8% | |
| GMDA | GAMIDA CELL LTD | $4,330,000 | -14.8% | 1,000,000 | 0.0% | 0.17% | -6.0% | |
| BLUE | BLUEBIRD BIO INC | $4,316,000 | -27.8% | 47,000 | 0.0% | 0.17% | -20.4% | |
| HCAT | New | HEALTH CATALYST INC | $3,955,000 | – | 125,000 | +100.0% | 0.16% | – |
| MGNX | MACROGENICS INC | $3,828,000 | -24.8% | 300,000 | 0.0% | 0.15% | -16.8% | |
| LJPC | LA JOLLA PHARMACEUTICAL CO | $3,740,000 | -4.9% | 425,000 | 0.0% | 0.15% | +4.9% | |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $3,610,000 | -9.3% | 54,400 | +8.8% | 0.14% | 0.0% |
| TORC | RESTORBIO INC | $3,536,000 | -13.3% | 400,000 | 0.0% | 0.14% | -4.7% | |
| ARVN | ARVINAS INC | $3,233,000 | -2.0% | 150,000 | 0.0% | 0.13% | +8.4% | |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $3,213,000 | -27.7% | 2,974,754 | +46.7% | 0.13% | -20.5% |
| TXG | New | 10X GENOMICS INC | $3,200,000 | – | 63,500 | +100.0% | 0.13% | – |
| FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $3,003,000 | -5.3% | 775,000 | +47.3% | 0.12% | +4.3% |
| CORV | CORREVIO PHARMA CORP | $2,400,000 | -7.4% | 1,200,000 | 0.0% | 0.10% | +2.1% | |
| MYOV | MYOVANT SCIENCES LTD | $2,340,000 | -42.5% | 450,000 | 0.0% | 0.09% | -36.7% | |
| MRSN | MERSANA THERAPEUTICS INC | $2,212,000 | -61.0% | 1,400,000 | 0.0% | 0.09% | -57.1% | |
| PRTK | PARATEK PHARMACEUTICALS INC | $1,944,000 | +8.2% | 450,000 | 0.0% | 0.08% | +18.5% | |
| THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $1,376,000 | +6.7% | 1,500,000 | 0.0% | 0.06% | +17.0% | ||
| NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $1,372,000 | +4.2% | 1,000,000 | 0.0% | 0.06% | +14.6% | ||
| RADIUS HEALTH INCnote 3.000% 9/0 | $1,367,000 | +0.4% | 1,500,000 | 0.0% | 0.05% | +10.2% | ||
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $1,321,000 | -62.5% | 875,000 | 0.0% | 0.05% | -58.3% | |
| CRVS | CORVUS PHARMACEUTICALS INC | $1,204,000 | -19.5% | 400,000 | 0.0% | 0.05% | -11.1% | |
| CLVS | CLOVIS ONCOLOGY INC | $1,006,000 | -73.6% | 256,000 | 0.0% | 0.04% | -71.0% | |
| PACIRA BIOSCIENCESnote 2.375% 4/0 | $988,000 | -3.7% | 1,000,000 | 0.0% | 0.04% | +5.4% | ||
| DERMIRA INCnote 3.000% 5/1 | $844,000 | -2.4% | 1,000,000 | 0.0% | 0.03% | +9.7% | ||
| NVAX | NOVAVAX INC | $816,000 | -14.3% | 162,500 | 0.0% | 0.03% | -2.9% | |
| KLDO | KALEIDO BIOSCIENCES INC | $753,000 | -35.1% | 100,050 | 0.0% | 0.03% | -28.6% | |
| PTI | PROTEOSTASIS THERAPEUTICS IN | $338,000 | -13.3% | 400,000 | 0.0% | 0.01% | -7.1% | |
| CVET | Sell | COVETRUS INC | $246,000 | -68.8% | 20,683 | -35.8% | 0.01% | -65.5% |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -30,000 | -100.0% | -0.02% | – |
| Exit | ALDER BIOPHARMACEUTICALS INCnote 2.500% 2/0 | $0 | – | -5,000,000 | -100.0% | -0.17% | – | |
| AXGN | Exit | AXOGEN INC | $0 | – | -603,970 | -100.0% | -0.43% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -182,800 | -100.0% | -0.49% | – |
| BIIB | Exit | BIOGEN INCcall | $0 | – | -97,500 | -100.0% | -0.82% | – |
| PRAH | Exit | PRA HEALTH SCIENCES INC | $0 | – | -240,000 | -100.0% | -0.86% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -242,500 | -100.0% | -1.15% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB CO | $0 | – | -1,050,000 | -100.0% | -1.72% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.4% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q3 2023 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 39 | Q3 2023 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 39 | Q3 2023 | 1.9% |
| ACADIA HEALTHCARE COMPANY IN | 38 | Q3 2023 | 4.4% |
| ASCENDIS PHARMA A/S | 35 | Q3 2023 | 1.3% |
| INVITAE CORP | 35 | Q3 2023 | 1.8% |
| BIOMARIN PHARMACEUTICAL INC | 35 | Q3 2023 | 1.3% |
| MACROGENICS INC | 35 | Q3 2023 | 0.5% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.1% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 3,413,906 | 5.6% |
| Compass Therapeutics, Inc. | February 14, 2023 | 5,333,188 | 4.2% |
| Mirum Pharmaceuticals, Inc. | February 14, 2023 | 1,795,733 | 4.9% |
| PhaseBio Pharmaceuticals IncSold out | February 14, 2023 | 0 | 0.0% |
| Sierra Oncology, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ARDELYX, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| CHIASMA, INCSold out | February 15, 2022 | 0 | 0.0% |
| FIVE PRIME THERAPEUTICS, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| F-star Therapeutics, Inc. | February 15, 2022 | 751,889 | 3.6% |
| Protara Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.